Flecainide in Ventricular Arrhythmias: From Old Myths to New Perspectives

Flecainide is an IC antiarrhythmic drug (AAD) that received in 1984 Food and Drug Administration approval for the treatment of sustained ventricular tachycardia (VT) and subsequently for rhythm control of atrial fibrillation (AF). Currently, flecainide is mainly employed for sinus rhythm maintenance...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavalle, Carlo, Trivigno, Sara, Vetta, Giampaolo, Magnocavallo, Michele, Mariani, Marco Valerio, Santini, Luca, Forleo, Giovanni Battista, Grimaldi, Massimo, Badagliacca, Roberto, Lanata, Luigi, Ricci, Renato Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397118/
https://www.ncbi.nlm.nih.gov/pubmed/34441994
http://dx.doi.org/10.3390/jcm10163696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397118/
https://www.ncbi.nlm.nih.gov/pubmed/34441994
http://dx.doi.org/10.3390/jcm10163696

Ejemplares similares